TSE:7741

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. More Details

Rewards

Earnings are forecast to grow 11.5% per year

Risk Analysis

No risks detected for 7741 from our risk checks.


Snowflake Analysis

Flawless balance sheet with moderate growth potential.


Similar Companies

Share Price & News

How has HOYA's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 7741 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

1.6%

7741

-1.7%

JP Medical Equipment

-0.9%

JP Market


1 Year Return

33.3%

7741

28.0%

JP Medical Equipment

0.9%

JP Market

Return vs Industry: 7741 exceeded the JP Medical Equipment industry which returned 27.5% over the past year.

Return vs Market: 7741 exceeded the JP Market which returned 0.8% over the past year.


Shareholder returns

7741IndustryMarket
7 Day1.6%-1.7%-0.9%
30 Day6.5%1.6%-0.2%
90 Day14.2%9.0%3.8%
1 Year34.4%33.3%29.2%28.0%3.4%0.9%
3 Year98.5%91.7%67.4%62.5%2.3%-4.9%
5 Year183.0%165.1%118.4%107.7%22.4%8.9%

Price Volatility Vs. Market

How volatile is HOYA's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is HOYA undervalued compared to its fair value and its price relative to the market?

41.74x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 7741 (¥12235) is trading above our estimate of fair value (¥7512.12)

Significantly Below Fair Value: 7741 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 7741 is poor value based on its PE Ratio (41.7x) compared to the JP Medical Equipment industry average (25.7x).

PE vs Market: 7741 is poor value based on its PE Ratio (41.7x) compared to the JP market (16.7x).


Price to Earnings Growth Ratio

PEG Ratio: 7741 is poor value based on its PEG Ratio (3.6x)


Price to Book Ratio

PB vs Industry: 7741 is overvalued based on its PB Ratio (7x) compared to the JP Medical Equipment industry average (2.2x).


Next Steps

Future Growth

How is HOYA forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

11.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7741's forecast earnings growth (11.5% per year) is above the savings rate (0.05%).

Earnings vs Market: 7741's earnings (11.5% per year) are forecast to grow slower than the JP market (17.4% per year).

High Growth Earnings: 7741's earnings are forecast to grow, but not significantly.

Revenue vs Market: 7741's revenue (6.9% per year) is forecast to grow faster than the JP market (5.2% per year).

High Growth Revenue: 7741's revenue (6.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 7741's Return on Equity is forecast to be high in 3 years time (21.6%)


Next Steps

Past Performance

How has HOYA performed over the past 5 years?

6.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 7741 has high quality earnings.

Growing Profit Margin: 7741's current net profit margins (20.2%) are lower than last year (21.8%).


Past Earnings Growth Analysis

Earnings Trend: 7741's earnings have grown by 6.7% per year over the past 5 years.

Accelerating Growth: 7741's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 7741 had negative earnings growth (-10.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-7.8%).


Return on Equity

High ROE: 7741's Return on Equity (17.3%) is considered low.


Next Steps

Financial Health

How is HOYA's financial position?


Financial Position Analysis

Short Term Liabilities: 7741's short term assets (¥499.3B) exceed its short term liabilities (¥100.9B).

Long Term Liabilities: 7741's short term assets (¥499.3B) exceed its long term liabilities (¥49.5B).


Debt to Equity History and Analysis

Debt Level: 7741's debt to equity ratio (0.2%) is considered satisfactory.

Reducing Debt: 7741's debt to equity ratio has reduced from 6.4% to 0.2% over the past 5 years.

Debt Coverage: 7741's debt is well covered by operating cash flow (10523.9%).

Interest Coverage: 7741 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is HOYA current dividend yield, its reliability and sustainability?

0.73%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 7741's dividend (0.74%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.33%).

High Dividend: 7741's dividend (0.74%) is low compared to the top 25% of dividend payers in the JP market (3.22%).


Stability and Growth of Payments

Stable Dividend: 7741's dividends per share have been stable in the past 10 years.

Growing Dividend: 7741's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (30.7%), 7741's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.3yrs

Average board tenure


CEO

Hiroshi Suzuki (62 yo)

17.33yrs

Tenure

JP¥168,000,000

Compensation

Mr. Hiroshi Suzuki has been the Chief Executive Officer of HOYA Corporation since June 2003 and has been its President since June 2000. Mr. Suzuki serves as Representative Executive Officer at HOYA Corpora ...


CEO Compensation Analysis

Compensation vs Market: Hiroshi's total compensation ($USD1.59M) is about average for companies of similar size in the JP market ($USD1.98M).

Compensation vs Earnings: Hiroshi's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Hiroshi Suzuki
Chairperson of the Board17.33yrsJP¥168.00m0.25%
¥ 11.6b
Takeo Takasu
Independent Director6.33yrsno data0.00075%
¥ 34.7m
Shuzo Kaihori
Independent Director5.33yrsno data0.00027%
¥ 12.5m
Mitsudo Urano
Lead Independent Director1.75yrsno data0.0013%
¥ 61.5m
Yukako Uchinaga
Independent Director7.33yrsno data0.00027%
¥ 12.5m
Hiroaki Yoshihara
Independent Director2.33yrsno datano data

5.3yrs

Average Tenure

72yo

Average Age

Experienced Board: 7741's board of directors are considered experienced (5.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

HOYA Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: HOYA Corporation
  • Ticker: 7741
  • Exchange: TSE
  • Founded: 1941
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: JP¥4.625t
  • Shares outstanding: 374.76m
  • Website: https://www.hoya.co.jp

Number of Employees


Location

  • HOYA Corporation
  • Nittochi Nishishinjuku Building
  • 20th Floor
  • Tokyo
  • 160-8347
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HOCP.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 1992
HYBDB (Deutsche Boerse AG)YesCommon StockDEEURJan 1992
7741TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYJan 1992
HOCP.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDSep 2004

Biography

HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The L ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/19 14:56
End of Day Share Price2020/10/16 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.